1 / 4

European Preventive Inhaler Market

European Preventive Inhaler Market Size, Industry Trends, Leading Players, Share and Forecast 2019-2025

supershiba
Télécharger la présentation

European Preventive Inhaler Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research European Preventive Inhaler Market Size, Industry Trends, Leading Players, Share and Forecast 2019-2025 For free sample request visit: https://www.omrglobal.com/request- sample/european-preventive-inhaler-market Contact Person: Mr. Anurag Tiwari Email: info@orionmarketreports.com Contact no: +1 646-755-7667, +91 780-304-0404

  2. The European preventive inhaler market was valued at around $2.8 billion in 2018 and is anticipated to grow at a substantial rate of 1.5% during the forecast period. Major countries that will contribute to the inhaler market within the region include UK, Germany, France, Italy and Spain. A significant number of companies, research, and patient base have been observed in the market due to which a significant growth can be observed in the market. Request a Free Sample of our Report on European Preventive Inhaler Market: https://www.omrglobal.com/request-sample/european-preventive-inhaler-market According to the International Monetary Fund (IMF), Europe is home to around 740 million people and the GDP of the European Union is $19.7 trillion in 2017. As per Organization for Economic Co-operation and Development (OECD), the self-reported asthma rate and COPD rate by European Union countries were 6.1% and 4.0% respectively and it has been found out that the rate of prevalence of diseases are higher in women as compared to men. This is expected to drive the regional business growth of the preventive inhaler market. The European preventive inhaler market is segmented on the basis of device type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler and dry powdered inhaler. The dry powder inhaler is estimated to have the largest market share in the European preventive inhaler market due to providing an easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest-growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing inhalers to cater to a wide range of customers within the region and across the globe. The major

  3. players of the European preventive inhaler market include Boehringer Ingelheim International GmbH, AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceuticals Industries Ltd., Koninklijke Philips N.V., and Bespak. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players. A Full Report of European Preventive Inhaler Market is Available at https://www.omrglobal.com/industry- reports/european-preventive-inhaler-market European Preventive Inhaler Market Segmentation By Device Type  Metered Dose Inhaler  Dry Powder Inhaler By Application  Asthma  Chronic Obstructive Pulmonary Disease (COPD) By End-User  Homecare  Hospitals and Clinics Regional Analysis  UK  Germany  France  Italy

  4. Spain  Rest of Europe Company Profiles  3M Co.  Acorda Therapeutics, Inc.  Adamis Pharmaceuticals Corp.  Adherium Ltd.  AstraZeneca PLC  Bespak  Boehringer Ingelheim International GmbH  Chiesi Farmaceutici S.P.A. For More Customized Data, Request for Report Customization @https://www.omrglobal.com/report- customization/european-preventive-inhaler-market About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related